Dietary patterns, inflammation, and dyslipidemia: A review of evidence and implications
DOI:
https://doi.org/10.31783/ELSR.2024.1026776Keywords:
cardiovascular disease, dietary inflammatory index, inflammationAbstract
Dyslipidemia refers to elevated levels of LDL (bad) cholesterol and triglycerides, accompanied by low HDL-cholesterol in the body which is one of the most significant modifiable contraindications for cardiovascular illness, and the leading cause of death worldwide. Inflammation plays a key role in the pathophysiological process of cardiovascular disease among dyslipidemic people. Numerous systematic reviews have revealed a link among biological markers of inflammation, including C-reactive protein (CRP), interleukin (IL)-1β, IL-6, tumor necrosis factor-alpha (TNF-α), IL-4, and IL-10 and cardiometabolic disease as well as proinflammatory diet impact on inflammation. Several studies have found that preventing and managing dyslipidemia may considerably decrease fatality and morbidness caused by atherosclerosis and cardiac ischemia. The three major strategies to cure dyslipidemia are to improve one's lifestyle, eat a healthier diet, and use medications of these three, a healthy dietary habit is the most important lifestyle component that influences an inflammatory response. The inclusion of various foodstuffs plus healthy eating habits may exert a positive impact on wellness due to the anti-inflammatory qualities they possess. The purpose of the present review article is to assess the overall results obtained from current articles whose research has explored the relationship between dyslipidemia with Dietary Inflammatory Index (DII) as well as its correlation with an elevated risk of cardiovascular disease. The dietary inflammatory index score is significant in the relationship between inflammation and cardiovascular disease among Dyslipidemia patients and is thoroughly evaluated, particularly in the context of healthy dietary habits.
References
[1] M. Arvanitis and C. J. Lowenstein (2023). Dyslipidemia. Ann. Intern. Med., 176: ITC81-ITC96. doi: 10.7326/AITC2023062.
[2] J. Ghosh (2023). A review on understanding the risk factors for coronary heart disease in Indian college students. Int. J. Non-Commun. Dis., 8: 117-128.
[3] R. K. Upadhyay (2023). High cholesterol disorders, myocardial infarction and its therapeutics. World J. Cardiovasc. Dis., 13: 433-469.
[4] K. R. Feingold (2000). Utility of advanced lipoprotein testing in clinical practice. In: K. R. Feingold, B. Anawalt, M. R. Blackman, A. Boyce, G. Chrousos, E. Corpas and W. W. de Herder et al., (Eds.), Endotext [Internet]; MDText.com, Inc.: South Dartmouth, MA, USA,
[5] A. Pirillo, M. Casula, E. Olmastroni, G. D. Norata and A. L. Catapano (2021). Global epidemiology of dyslipidaemias. Nat. Rev. Cardiol., 18: 689-700
[6] K. C. Gracia and D. L.-Cornejo and H. Husi (2017). CVD and Oxidative Stress. J Clin Med 6: 22. doi: 10.3390/jcm6020022.
[7] Q. Yang, M. E. Cogswell, W. D. Flanders, Y. Hong, Z. Zhang, F. Loustalot and C. Gillespie et al., (2012). Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 307: 1273-1283.
[8] M. J. Feinstein (2024). Statins, inflammation, and tissue context in REPRIEVE. JAMA Cardiol., 9: 334-335.
[9] R. Hariharan, E. N. Odjidja, D. Scott, N. Shivappa, J. R. Hébert, A. Hodge and B. De Courten (2022). The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases. Obes. Rev., 23: e13349. doi: 10.1111/obr.13349.
[10] A. J. Berberich and R. A. Hegele (2022). A modern approach to dyslipidemia. Endocr. Rev., 43: 611-653.
[11] J. R. Hébert, N. Shivappa, M. D. Wirth, J. R. Hussey and T. G. Hurley (2019). Perspective: the Dietary Inflammatory Index (DII)—lessons learned, improvements made, and future directions. Adv. Nutr., 10: 185-195.
[12] M. D. Wirth, J. R. Hébert, N. Shivappa, G. A. Hand, T. G. Hurley, C. Drenowatz and D. McMahon et al., (2016). Anti-inflammatory dietary inflammatory index scores are associated with healthier scores on other dietary indices. Nutr. Res., 36: 214-219.
[13] S. Sood, J. Feehan, C. Itsiopoulos, K. Wilson, M. Plebanski, D. Scott and J. R. Hebert et al., (2022). Higher adherence to a mediterranean diet is associated with improved insulin sensitivity and selected markers of inflammation in individuals who are overweight and obese without diabetes. Nutrients, 14: 4437, doi: 10.3390/nu14204437.
[14] Q. Jin, P. A. Hart, N. Shi, J. J. Joseph, M. Donneyong, D. L. Conwell and S. K. Clinton (2021). Dietary patterns of insulinemia, inflammation and glycemia, and pancreatic cancer risk: findings from the women’s health initiative. Cancer Epidemiol. Biomarkers Prev., 30: 1229-1240.
[15] M. Hedayatnia, Z. Asadi, R. Z.-Feyzabadi, M. Y.-Khorasani, H. Ghazizadeh, R. G.-Zirak and A. N.-Tirkani (2020). Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis., 19: 42. doi: 10.1186/s12944-020-01204-y.
[16] R. Gupta, R. S. Rao, A. Misra and S. K. Sharma (2017). Recent trends in epidemiology of dyslipidemias in India. Indian Heart J., 69: 382-392
[17] S. Mohanraj, G. Velmurugan, K. Swaminathanand A. Ramakrishnan (2023). Prevalence and risk factors for dyslipidemia among South Indian adults: A community based-NCD study. Int. J. Diabetes Dev. Ctries., 43: 936-945
[18] G. T. Gau and R. S. Wright (2006). Pathophysiology, diagnosis, and management of dyslipidemia. Curr. Probl. Cardiol., 31: 445-486
[19] A. F. M. Halawani, Z. S. Alahmari, D. A. Asiri, A. A. Albraheem, A. M. A. Alsubaie, A. G. Alqurashi and F. M. Alturkistani et al., (2019). Diagnosis and Management of Dyslipidemia. Arch. Pharm. Pract., 10: 67-70.
[20] S. M. Grundy, N. J. Stone, A. L. Bailey, C. Beam, K. K. Birtcher, R. S. Blumenthal and L. Braun et al., (2019). Guideline on the management of blood cholesterol: A report of the American college of cardiology/American heart association task force on clinical practice guidelines. Circulation, 139: e1082-e1143.
[21] L. Su, R. Mittal, D. Ramgobin, R. Jain and R. Jain (2021). Current management guidelines on hyperlipidemia: The silent killer. Journal Lipi., Article ID 9883352, doi: 10.1155/2021/9883352.
[22] G. Bereda (2022). Pathophysiology and management of dyslipidaemia. Biomed. J. Sci. Tech. Res., 43: 34369-34375.
[23] A. K. Chopra (2024). Dietary management of dyslipidemia. Indian Heart J., 76: S65-S72.
[24] A. S. Kumar and N. Sinha (2020). Cardiovascular disease in India: A 360 degree overview. Med. J. Armed Forces India, 76: 1-3.
[25] G. A. Roth, C. Johnson, A. Abajobir, F. Abd-Allah, S. F. Abera, G. Abyu and M. Ahmed et al., (2017). Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J. Am. Coll. Cardiol., 70: 1-25.
[26] S. Ansari (2021). Heart health and nutraceuticals. In: C. Egbuna, A. P. Mishra, M. R. Goyal (Eds.), Preparation of Phytopharmaceuticals for the Management of Disorders. Elsevier, Academic Press, pp255-272. ISBN: 978-0-12-820284-5.
[27] S. Elias, Y. Chen, X. Liu, S. Slone, R.-A. T.-Ocran, B. Ogungbe and S. Thomas et al., (2024). Shared Decision-Making in Cardiovascular Risk Factor Management: A Systematic Review and Meta-Analysis. JAMA Netw. Open, 7: e243779. doi: 10.1001/jamanetworkopen.2024.3779.
[28] J. D. Schofield, Y. Liu, P. Rao-Balakrishna, R. A. Malik and H. Soran (2016). Diabetes Dyslipidemia. Diabetes Ther., 7: 203-219.
[29] M. B. Katan (2006). The response of lipoproteins to dietary fat and cholesterol in lean and obese persons. Curr. Cardiol. Rep., 8: 446-451.
[30] X. Chen, C. Hou, L. Yao, J. Li, M. Gui, M. Wang and X. Zhou et al., (2023). Dietary inflammation index is associated with dyslipidemia: evidence from national health and nutrition examination survey, 1999–2019. Lipids Health Dis., 22: 149. doi: 10.1186/s12944-023-01914-z.
[31] N. Shivappa, S. E. Steck, T. G. Hurley, J. R. Hussey and J. R. Hébert (2014). Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr., 17: 1689-1696.
[32] H. Xu, Q. Wen, X. Xing, Y. Chen, Q. Zhu, M. Tan and M. Zhang et al., (2024). High dietary inflammatory index increases the risk of female infertility: An analysis of NHANES 2013-2018. Nutr Res., 125: 50-60.
[33] M. Bujtor, A. Turner, S. Torres, L. Esteban-Gonzalo, C. Pariante and A. Borsini (2021). Associations of dietary intake on biological markers of inflammation in children and adolescents: A systematic review. Nutrients, 13: 356. doi: 10.3390/nu13020356.
[34] N. H.-Esfahani, S. Hajahmadi, Y. Pasdar, M. Darbandi, F. Najafi, M. Moradinazar and M. Bonyani, et al., (2024). Diet-related inflammation is positively associated with atherogenic indices. Sci. Rep., 14: 13190. doi: 10.1038/s41598-024-63153-1.
[35] Y. Pasdar, F. Moradi, S. Cheshmeh, M. Sedighi, A. Saber, S. Moradi and M. Bonyani et al., (2023). Major dietary patterns and dietary inflammatory index in relation to dyslipidemia using cross-sectional results from the RaNCD cohort study. Sci. Rep., 13: 19075. doi: 10.1038/s41598-023-46447-8.
[36] L. Wang, T. Liu, Q. Zhang, L. Wang, Q. Zhou, J. Wang and H. Miao et al., (2023). Correlation between dietary inflammation and mortality among hyperlipidemics. Lipids Health Dis., 22: 206. doi: 10.1186/s12944-023-01975-0.
[37] S. Ghorabi, A. Esteghamati, K. Azam, E. Daneshzad, O. Sadeghi, A. S.-Moghaddam, L. Azadbakht et al., (2020). Association between dietary inflammatory index and components of metabolic syndrome. J. Cardiovasc. Thorac. Res., 12: 27-34.
[38] D. S. Sajjanar and P. Nimbal (2019). Association between dietary inflammatory index and metabolic syndrome: A hospital-based study. J. Krishna Inst. Med. Sci. University, 8: 20-29.
[39] A. Agarwala, K. S. Petersen, F. Jafari, P. M. Kris-Etherton (2022). Dietary management of dyslipidemia and the impact of dietary patterns on lipid disorders. Prog. Cardiovasc. Dis., 75: 49-58.
[40] A. J. Nordmann, A. Nordmann, M. Briel, U. Keller, W. S. Yancy, B. J. Brehm and H. C. Bucher (2006). Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch. Intern. Med., 166: 285-293.
[41] S. B. Seidelmann, B. Claggett, S. Cheng, M. Henglin, A. Shah, L. M. Steffen, A. R. Folsom et al., (2018). Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Heal., 3: e419–e428
[42] S. M. Ahmed, M. E. Clasen and J. E. Donnelly (1998). Management of dyslipidemia in adults. Am. Fam. Physician., 57: 2192-2204.
[43] A. Poli, F. Marangoni, R. Paoletti, E. Mannarino, G. Lupattelli, A. Notarbartolo and P. Aureli et al., (2008). Non-pharmacological control of plasma cholesterol levels. Nutr. Metab. Cardiovasc. Dis., 18: S1-S16.
[44] N. D. Barnard (2022). Dyslipidemias. In: Nutrition Guide for Clinicians. https://nutritionguide.pcrm.org/nutritionguide/view/Nutrition_Guide_for_Clinicians/1342002/all/Dyslipidemias.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Author (s)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright © The Author(s). Effective from 1 July 2026, articles published in Emergent Life Sciences Research (ELSR) are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, distribution, reproduction, and adaptation in any medium or format, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any changes made are indicated.
Articles published before 1 July 2026 remain subject to the license applicable at the time of their original publication, including the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), where applicable.
